BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Syros To Present New Preclinical PK And PD Data On SY-1365, Its First-In-Class Selective CDK7 Inhibitor, At AACR-NCI-EORTC Conference

  Syros Pharmaceuticals today announced that the Company will present preclinical pharmacokinetic (PK) and pharmacodynamic (PD) data on SY-1365 at the 2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference taking place October 26-30 in Philadelphia.

  October 16, 2017

   · 

  4 min read
• Business

  Vertex To Announce Third Quarter 2017 Financial Results On October 25

  Vertex will report its third quarter 2017 financial results on Wednesday, October 25, 2017 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

  October 16, 2017

   · 

  1 min read
• Policy

  FDA Accepts Bristol-Myers Squibb’s Application For Opdivo (Nivolumab) In Patients With Resected High-Risk Advanced Melanoma And Grants Priority Review

  Bristol-Myers Squibb Company announced today that FDA has accepted for priority review its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) to treat patients with melanoma who are at high risk of disease recurrence following complete surgical resection.

  October 16, 2017

   · 

  32 min read
• Business

  Henry Schein Medical Announces Exclusive Distribution Agreement With Terason® For Ultrasound Device

  Henry Schein Medical today announced that its EMS business has entered an exclusive agreement with Terason to distribute uSmart 3200T NexGen.

  October 16, 2017

   · 

  4 min read
• Biotech Beach

  Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release And Conference Call

  Tandem Diabetes Care plans to release its third quarter 2017 results after the financial markets close on Thursday, October 26, 2017.

  October 16, 2017

   · 

  2 min read
• Drug Development

  PROMETRIKA To Coordinate Second Phase I Trial For MD Anderson’s Institute For Applied Cancer Science

  PROMETRIKA, LLC, a boutique full service Clinical Research Organization (CRO), is coordinating a Phase 1 trial for The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science.

  October 16, 2017

   · 

  1 min read
• Business

  Senseonics Holdings, Inc. Schedules Third Quarter 2017 Earnings Release And Conference Call For October 31, 2017 At 4:30 P.M. Eastern Time

  Senseonics Holdings, Inc. today announced that it plans to release its third quarter 2017 financial results after market close on Tuesday, October 31, 2017.

  October 16, 2017

   · 

  1 min read
• Biotech Beach

  CytRx Corp. Announces Outcome of Nasdaq Hearing

  CytRx Corp. today announced that Nasdaq has granted the Company’s request for a continued listing pending the results of a stockholder vote on or before October 30, 2017.

  October 16, 2017

   · 

  7 min read
• Policy

  Mylan Invalidates Allergan’s Patents on Restasis

  Mylan today announced that the United States District Court for the Eastern District of Texas has issued a 135-page decision finding all asserted claims of the patents relating to Restasis invalid based on obviousness.

  October 16, 2017

   · 

  5 min read
• Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

  Valeant announced today the results to date of the pending cash tender offers by Valeant and Valeant Pharmaceuticals International to purchase up to $1,000,000,000 aggregate principal amount of their respective outstanding notes.

  October 16, 2017

   · 

  10 min read